Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 9/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 5/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29311777 | 0.92 | ALDH1A1 (0.50) | HPGDALDH1A1MAPK1MAPTTHRB | |
| SCHEMBL4461870 | 0.88 | THRB (0.47) | HPGDALDH1A1MAPK1MAPTTHRB | |
| SCHEMBL26124187 | 0.88 | ALDH1A1 (0.54) | HPGDALDH1A1MAPK1MAPTTHRB | |
| SCHEMBL24565139 | 0.84 | MTNR1A (0.52) | HPGDALDH1A1THRBTSHRTP53 | |
| SCHEMBL556653 | 0.84 | THRB (0.44) | HPGDALDH1A1MAPK1THRBTSHR | |
| SCHEMBL7524595 | 0.84 | KDM4E (0.51) | HPGDALDH1A1MAPK1MAPTTHRB | |
| SCHEMBL10455358 | 0.84 | THRB (0.44) | HPGDALDH1A1MAPK1MAPTTHRB | |
| SCHEMBL42562 | 0.83 | THRB (0.58) | HPGDALDH1A1MAPK1MAPTTHRB | |
| SCHEMBL24565133 | 0.82 | THRB (0.43) | HPGDALDH1A1MAPK1MAPTTHRB | |
| SCHEMBL16893753 | 0.81 | THRB (0.53) | HPGDALDH1A1MAPK1MAPTTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11693310-B2 | Blue curable resin composition, blue color filter, and display device including same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-07-04 | — | — | US | disclosed |
| US-11693310-B2 | Blue curable resin composition, blue color filter, and display device including same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-07-04 | — | — | US | disclosed |
| US-20230056225-A1 | PHOTOSENSITIVE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-02-23 | — | — | US | disclosed |
| US-20230028822-A1 | PHOTOSENSITIVE INK COMPOSITION, CURED PRODUCT, DISPLAY PANEL, AND METHOD FOR PRODUCING CURED PRODUCT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
| US-20230002520-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-01-05 | — | — | US | disclosed |
| US-20220404709-A1 | PHOTOSENSITIVE INK COMPOSITION, CURED PRODUCT, DISPLAY PANEL, AND METHOD FOR PRODUCING CURED PRODUCT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2022-12-22 | — | — | US | disclosed |
| EP-4019558-A1 | CURABLE INK COMPOSITION, CURED MATERIAL AND NANOCOMPOSITE | TOKYO OHKA KOGYO CO., LTD. (JP) | 2022-06-29 | — | — | EP | disclosed |
| US-20200371435-A1 | BLUE CURABLE RESIN COMPOSITION, BLUE COLOR FILTER, AND DISPLAY DEVICE INCLUDING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-11-26 | — | — | US | disclosed |
| US-9051397-B2 | Oxime ester | BASF SE (DE) | 2015-06-09 | — | — | US | disclosed |
| US-9051397-B2 | Oxime ester | BASF SE (DE) | 2015-06-09 | — | — | US | disclosed |
| EP-2625166-B1 | OXIME ESTER DERIVATIVES OF BENZOCARBAZOLE COMPOUNDS AND THEIR USE AS PHOTOINITIATORS IN PHOTOPOLYMERIZABLE COMPOSITIONS | BASF SE (DE) | 2014-09-24 | — | — | EP | disclosed |
| US-20130188270-A1 | OXIME ESTER | BASF SE (DE) | 2013-07-25 | — | — | US | disclosed |
| US-20130188270-A1 | OXIME ESTER | BASF SE (DE) | 2013-07-25 | — | — | US | disclosed |
| WO-2012045736-A1 | OXIME ESTER DERIVATIVES OF BENZOCARBAZOLE COMPOUNDS AND THEIR USE AS PHOTOINITIATORS IN PHOTOPOLYMERIZABLE COMPOSITIONS | BASF SE (DE) | 2012-04-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130188270-A1 | OXIME ESTER | CBR3, CBR1, COX15 | HPGD 51/4885ALDH1A1 738/4885MAPK1 4021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.